Oncology drugs are clearly the focus of development going into the future, while drugs for infectious disease and central nervous system also make up a large proportion of R&D spend.

Figure 1: Number of pipeline drugs in the US, by therapy area

Source: GlobalData, Pharma Intelligence Center, Drug Database [Accessed 1 November 2017]

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData